Abortion Pills

Medication abortion uses two FDA-approved oral medications to end a pregnancy: mifepristone and misoprostol, commonly referred to as “abortion pills.” Mifepristone interrupts the flow of the hormone progesterone that sustains the pregnancy, and misoprostol causes contractions to expel the contents of the uterus. You can use these pills in combination or use misoprostol alone.

Abortion pills are extremely safe. Serious adverse events occur in less than one-third of one percent of medication abortions. Abortion pills are over 95 percent effective when used within 10 weeks of the first day of your last menstrual period.

The organization Plan C has a comprehensive guide to finding abortion pills on their website at www.plancpills.org. Select “Find Abortion Pills” and then select the state where you are located from the drop-down menu. The website is continually updated and has all the latest information on where to find abortion pills from anywhere in the U.S.

A Government for Big Tobacco and Bigger Families

PUBLISHED 5/14/2026 by

The Department of Health and Human Services (HHS) made multiple headlines this week—starting with the on-again-off-again tenure of Dr. Marty Makary in his role as FDA commissioner. The FDA has drawn the ire of antiabortion activists over the agency’s approach to mifepristone regulation, including its approval last year of a generic version of the drug.

A so-called “safety report” on mifepristone, commissioned by HHS, is not due to be issued by the FDA until the fall, keeping the issue out of the public eye in the leadup to the midterms. (The timing, quite frankly, is a boon to Republicans.)

The real concern that appears to have been the final straw for the commissioner? Flavored vapes. Whereas the White House has been waging a campaign to appease tobacco donors by authorizing mint, tea and spice-flavored e-cigarettes, in March, the FDA issued a memo saying that it would draw the line at fruit and candy flavors. (Always looking out for the kids.) Yet somehow last week, blueberry and mango made it over the finish line. Sweet enough to satisfy Big Tobacco? Time will tell.

There’s nothing quite like coining a word like “under-babied” while peddling fruity vapes—all while gas prices are soaring, workplace benefits for parents are being rolled back, health insurance remains out of reach for millions, affordable housing is an oxymoron, and on and on.

Such is the legacy of a single week of news out of our nation’s top federal health agency.

The Supreme Court Keeps Mifepristone Available by Mail as Litigation Continues

PUBLISHED 5/14/2026 by | UPDATED 5/15/2026 at 10:33 A.M. PT

The mifepristone case that has landed on the Supreme Court’s shadow docket is the new face of conservative efforts to impose a nationwide ban on abortion.

It’s possible that the Court is close and needs a little more time to reach a decision. There has been some thought it might set the case for argument on the merits as early as next month, or more realistically, next term, and decide it on the merits quickly, at least as courts count time.

But given the political weight of the issue in a midterm election year, the Court could also return to its history with mifepristone: kicking the can down the road. That’s what they did when the Texas case, Alliance for Hippocratic Medicine v. FDA, came before it in June 2024, deciding that the plaintiffs lacked standing and dismissing the case, instead of ruling on the substantive issue.

The Supreme Court Preserved Mail-Order Abortion Pills—for Now. Julie Kay Says Providers Are Still Preparing.

PUBLISHED 5/14/2026 by | UPDATED 5/15/2026 at 12:02 P.M. PT

Thursday, May 14, at 5 p.m. ET, the Supreme Court’s temporary stay in the mifepristone case is set to expire, once again leaving abortion providers, patients and advocates waiting to see whether the Court will extend the pause, or allow the Fifth Circuit’s restrictions on mifepristone to take effect.

If the Court does nothing, the lower-court ruling could snap back into place, threatening mail-order and telemedicine access to mifepristone, one of the two drugs commonly used in medication abortion.

But abortion rights advocates say the story does not end there. Telemedicine abortion networks, shield-law protections, advance provision and community-based access have already reshaped abortion care in the post-Dobbs landscape—and those systems are continuing to evolve.

Julie F. Kay, a human rights lawyer and founder and executive director of Reproductive Futures, has spent years working at the intersection of reproductive rights, telemedicine abortion and shield-law protections. She co-founded the Abortion Coalition for Telemedicine, challenged Ireland’s abortion ban before the European Court of Human Rights, and co-authored Controlling Women: What We Must Do Now to Save Reproductive Freedom.

Keeping Score: Supreme Court Blow to Voting Rights Will ‘Silence Our Voices’; Conservative Judges Try to Restrict Mifepristone; Moms Worry About Putting Food on the Table

PUBLISHED 5/14/2026 by | UPDATED 5/15/2026 at 10:38 A.M. PT

In every issue of Ms., we track research on our progress in the fight for equality, catalogue can’t-miss quotes from feminist voices and keep tabs on the feminist movement’s many milestones. We’re Keeping Score online, too—in this biweekly roundup.

This week:
—The Supreme Court gutted the Voting Rights Act, slashing protections against racially discriminatory voting laws.
—A record high amount of books were censored from libraries in 2025, often due to LGBTQ characters or plotlines addressing racism.
—A third of moms living on low incomes have gone into debt or skipped meals so their kids could eat.
—Just 22 percent of American voters have significant confidence in the Supreme Court.
—In 2025 the number of abortions in the U.S. remained stable, but more patients in states with bans turned to telehealth services instead of traveling out of state.
—The Department of Justice announced plans to expand the use of the federal death penalty.
—An Epstein-Maxwell survivor, who asked to remain anonymous, laments, “I kept my identity protected as Jane Doe. I woke up one day with my name mentioned over 500 times. While the rich and powerful remain protected by redaction, my name was exposed to the world.”
—The Trump administration launched a Moms.gov site on Mother’s Day that refers pregnant people to unregulated crisis pregnancy centers.
—A Ms. piece on solitary confinement by Kwaneta Harris and her daughter Summer Knight won Kwaneta second place in the Collaboration category of the Stillwater Awards for prison journalism.
—Liberation, a play about 1970s feminism by Bess Wohl, won the Pulitzer Prize for drama. It was also nominated for the Tony Award for Best Play. Wohl was inspired by her own life: Her mother, Lisa Cronin Wohl, was an early Ms. contributor.

… and more.

Yes, You Can Still Get Abortion Pills by Mail—Here’s What to Know

PUBLISHED 5/11/2026 by | UPDATED 5/15/2026 at 10:40 A.M. PT

On May 1, the Fifth Circuit Court of Appeals issued a sweeping ruling seeking to prohibit telehealth prescribing of mifepristone, forcing women to see a provider in-person to acquire the first pill in the standard two-drug medication abortion regimen. The decision would have blocked U.S. clinicians from mailing abortion pills after telehealth consultations nationwide.

On May 4, however, the U.S. Supreme Court temporarily paused that ruling, preserving current telehealth and mail access while the justices consider next steps. The Court’s temporary ruling was set to last until 5 p.m. ET on Monday, May 11, giving the justices time to decide whether to extend the pause or let the lower-court ruling take effect.

Then, on Monday afternoon, the U.S. Supreme Court briefly extended its temporary order preserving telehealth and mail access to mifepristone while the justices continue deliberating over the emergency appeal. Justice Samuel Alito extended the Court’s administrative stay through Thursday, May 14, at 5 p.m. ET, keeping on hold the Fifth Circuit’s May 1 ruling that would have required patients nationwide to obtain the medication through in-person visits. The order means that, for now, people can still access mifepristone through telehealth consultations and mail delivery under the current FDA rules.

National Institute for Reproductive Health president Christian LoBue said the Supreme Court’s decision “preserves telehealth access to mifepristone for now,” but warned it also “prolongs an untenable state of uncertainty for patients and providers nationwide.” Antiabortion forces are “focused on creating chaos and fear, not improving health outcomes,” she said, urging states to instead focus on strengthening protections for providers, patient privacy and access to medication abortion.

Regardless of what the courts ultimately decide, abortion access advocates, international telehealth providers and community networks say they are prepared to continue helping people access abortion pills.

Either way, the infrastructure for medication abortion access already exists—and it is not disappearing.

The Fifth Circuit Proves Abortion Is on the Ballot this November

PUBLISHED 5/7/2026 by | UPDATED 5/15/2026 at 10:41 A.M. PT

A highlight of being in Ireland has been following the local news, especially the robust abortion beat: Irish lawmakers have been waging a loud fight to expand abortion rights—in particular, to ensure unnecessary waiting periods don’t impede access to care.

Breaking headlines from the United States were a dark juxtaposition.

The U.S. is one of only four nations worldwide actively rolling back reproductive rights.

And now we’re threatened with yet another fight: The Fifth Circuit Court of Appeals issued a ruling late last week aiming to create the most significant setback to abortion access since the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision four years ago.

The three-member panel, two of whom are Trump appointees, blocked a 2023 FDA policy allowing mifepristone to be prescribed by telehealth providers and delivered by mail—a decision that applies to all states, whether abortion is legal or not, and where voters have mobilized to pass ballot measures and enshrine reproductive rights in their state constitutions.

This Fifth Circuit ruling is not the final word on the case. The two pharmaceutical companies that make mifepristone, Danco and GenBioPro, immediately filed an emergency appeal to the Supreme Court. On Monday, Justice Samuel Alito announced an administrative stay through May 11, meaning the decision is on hold until at least then, while the justices review the appeal and decide whether the medically unnecessary in-person dispensing requirements can be reimposed for the duration of the litigation.

In the spirit of the fighting Irish, readers should take heart that the community of U.S. abortion providers, advocates and support networks “have shown amazing resilience and tenacity since the Dobbs decision,” according to Kelly Baden of Guttmacher. “They will continue to do what they can do to ensure that everyone, regardless of where they live, can access the abortion care they need.”

So, for now, our citizen mobilization strategy must be twofold: Support those who directly deliver those services and get ready to get loud. The abortion fight shows that access to healthcare, the integrity of science, the rules of democracy, and the right to bodily autonomy are not only all interconnected, but they are all on the ballot this November.

The Courts Keep Targeting Abortion Pills. Patients and Providers Keep Finding Ways Around Them.

PUBLISHED 5/1/2026 by | UPDATED 5/15/2026 at 10:43 A.M. PT

The U.S. Supreme Court has temporarily paused the Fifth Circuit’s Friday ruling that would have tightened access to mifepristone, preserving the current status quo while the justices consider the emergency appeal. The order keeps telehealth and mail access in place for now.

The Monday morning emergency action from the Court—which orders the Trump administration to answer by May 7—follows an urgent intervention from the manufacturers of mifepristone, GenBioPro and Danco.

Regardless of what the courts decide, international telehealth providers, community networks and websites selling pills are ready to ramp up services to fill the needs of Americans.

War on Women Report: Rise of ‘Sleep Porn’; Georgia Midwives Sue for Right to Practice; Louisiana Family Massacre Exposes Deadly Intersection of Domestic Violence and Guns

PUBLISHED 4/29/2026 by and

MAGA Republicans are back in the White House, and Project 2025 is their guide: the right-wing plan to turn back the clock on women’s rights, remove abortion access, and force women into roles as wives and mothers in the “ideal, natural family structure.”

We know an empowered female electorate is essential to democracy. That’s why day after day, we stay vigilant in our goals to dismantle patriarchy at every turn. We are watching, and we refuse to go back. This is the War on Women Report.

Since our last report:
—Access to mifepristone remains protected for now, after a U.S. district court granted a stay in Louisiana v. FDA.
—A new CNN investigation reveals a sprawling online network where drug-facilitated sexual assault, marketed as “sleep porn, ” is filmed, shared and monetized, drawing millions of viewers. Meanwhile, survivors face steep barriers to reporting and justice.
—The Ohio House passed the Indecent Exposure Modernization Act, an extreme bill that seeks to ban any expression or performance of drag where minors are or may be present. The proposed ban includes even daytime family-oriented events such as drag queen story hours, where performers dress up as storybook characters and read to children at libraries or bookstores.
—In a devastating shooting spree spanning three locations, Shamar Elkins shot and killed eight children, seven of whom were his own, and severely wounded two women: his wife, Shaneiqua Pugh, and Christina Snow. Both women are mothers to the deceased victims.
—In Georgia, a group of reproductive healthcare advocates is challenging the state’s restrictions on some forms of maternal healthcare, arguing that Georgia’s current laws give doctors too much control over midwives’ ability to practice.
—Nine women in Tennessee are suing the state over its abortion ban after nearly denying due to being denied abortion care.

… and more.

Keeping Score: Pennsylvania ERA Secures Abortion Rights Win; Civil Rights Groups Investigate Trump Admin Delays in Childcare Payments; Senate Upholds Near-Total VA Abortion Ban

PUBLISHED 4/23/2026 by

In every issue of Ms., we track research on our progress in the fight for equality, catalogue can’t-miss quotes from feminist voices and keep tabs on the feminist movement’s many milestones. We’re Keeping Score online, too—in this biweekly roundup.

This week:
—In a landmark ruling shaped by Pennsylvania’s ERA, a state court struck down a decades-old ban on using Medicaid funds for abortion.
—Trump continued to attack voting rights, threatening mail-in ballots and moving towards a nationalized registration database full of errors.
—An estimated 8 million people attended the latest “No Kings” protests.
—A Michigan court ruled that the state’s Pregnancy Exclusion law, which prevents providers from honoring pregnant women’s documented end-of-life decisions, violates a voter-approved 2022 constitutional amendment.
—A federal judge blocked RFK Jr.’s changes to routine vaccination schedules.
—The Supreme Court ruled against Colorado’s ban on dangerous “conversion therapy” for LGBTQ youth.
—Housing markets are declining in states with abortion bans as young people leave or avoid those areas.
—Senators demand the Trump Administration release lifesaving Title X funding.
—Twenty-five states received a failing grade on access to sexual and reproductive healthcare.
—High levels of contamination were found in braiding hair.
—Women are driven away from coaching college sports by pay inequities and other systemic barriers.

… and more.